2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients

[1]  Abhishek Banerjee,et al.  T2 measurement of J‐coupled metabolites in the human brain at 3T , 2012, NMR in biomedicine.

[2]  R. Deberardinis,et al.  Measurement of glycine in the human brain in vivo by 1H‐MRS at 3 T: application in brain tumors , 2011, Magnetic resonance in medicine.

[3]  R. Deberardinis,et al.  Isocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors , 2011, Pediatric blood & cancer.

[4]  B. Christensen,et al.  DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. , 2011, Journal of the National Cancer Institute.

[5]  A. von Deimling,et al.  The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations , 2011, Brain pathology.

[6]  D. Rakheja,et al.  Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate , 2011, Tumor Biology.

[7]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[8]  E. Maher,et al.  Improvement of resolution for brain coupled metabolites by optimized 1H MRS at 7 T , 2010, NMR in biomedicine.

[9]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[10]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[11]  Andrey Korshunov,et al.  Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.

[12]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[13]  L. Chin,et al.  Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. , 2006, Cancer research.

[14]  M. Vincent,et al.  l‐2‐Hydroxyglutaric aciduria: clinical, genetic, and brain MRI characteristics in two adult sisters , 2006, European journal of neurology.

[15]  R.J. Gillies,et al.  pH imaging , 2004, IEEE Engineering in Medicine and Biology Magazine.

[16]  Jürgen Gieseke,et al.  1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.

[17]  Kiyohiro Houkin,et al.  In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. , 2004, Magnetic resonance imaging.

[18]  Robert J Gillies,et al.  pH imaging. A review of pH measurement methods and applications in cancers. , 2004, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[19]  H. Krawczyk,et al.  Characterisation of the 1H and 13C NMR spectra of N-acetylaspartylglutamate and its detection in urine from patients with Canavan disease. , 2003, Journal of pharmaceutical and biomedical analysis.

[20]  R. Sener.  L-2 hydroxyglutaric aciduria: proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging findings. , 2003, Journal of computer assisted tomography.

[21]  A. Gryff-Keller,et al.  1H and 13C NMR study of 2‐hydroxyglutaric acid and its lactone , 2002 .

[22]  E Moser,et al.  Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.

[23]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[24]  F. Gorin,et al.  Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. , 2000, American journal of physiology. Cell physiology.

[25]  P. Allen,et al.  Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification , 1999, Magnetic resonance in medicine.

[26]  S F Keevil,et al.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. , 1998, Magnetic resonance imaging.

[27]  M. Garwood,et al.  Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.

[28]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[29]  J. Griffiths.  Are cancer cells acidic? , 1991, British Journal of Cancer.

[30]  G. Bodenhausen,et al.  Principles of nuclear magnetic resonance in one and two dimensions , 1987 .

[31]  Paul A. Bottomley,et al.  4480228 Selective volume method for performing localized NMR spectroscopy , 1985 .

[32]  K Suzuki,et al.  SUBACUTE SCLEROSING LEUKOENCEPHALITIS: II. CHEMICAL STUDIES INCLUDING ABNORMAL MYELIN AND AN ABNORMAL GANGLIOSIDE PATTERN , 1966, Journal of neuropathology and experimental neurology.